Hospital de Clinicas José de San Martín
13
5
5
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.7%
1 terminated/withdrawn out of 13 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
HIBA-Institutional Registry of Amyloidosis
Role: collaborator
Fluorescent Cholangiography vs White Light for Bile Ducts Identification
Role: collaborator
Automatic Detection of Dyspnea in Mechanically Ventilated, Critically Ill Patients
Role: lead
Role of Mucosal Impedance Measurement for the Diagnosis of Gastroesophageal Reflux Disease
Role: lead
Usefulness of Wireless pH Monitoring in GERD Diagnosis
Role: lead
Body Composition Estimated by Bioelectrical Impedance Analysis in Patients with Acute Coronary Syndrome.
Role: lead
Cellular Immunity, Neuroendocrine, and Inflammatory Factors for Clinical Prognosis in Acute Coronary Syndrome
Role: lead
Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant
Role: lead
Impact of the Microsurgical Technique After a Theoretical-practical Course in Microsurgery
Role: lead
Tannin Specific Natural Extract for COVID-19 Infection
Role: lead
SARS-CoV 2 in Personal Protective Equipment
Role: lead
Standard-PCNL vs Mini-PCNL vs Super-mini PCNL for the Treatment of ≥2 cm Renal Stone
Role: collaborator
Lupus Flares and Histological Renal Activity at the End of the Treatment (LuFla)
Role: lead
All 13 trials loaded